logo

News

Bregal Unternehmerkapital sells proALPHA stake

Munich/Weilerbach, 8 August 2017 – Funds advised by Bregal Unternehmerkapital have sold their majority holding in enterprise resource planning (ERP) provider proALPHA. These shares were acquired by the management team and by funds advised by the international investment firm Intermediate Capital Group (ICG). Bregal will remain involved in the further development of proALPHA through a continuing interest. The transactions are pending, subject to approval by competition authorities.   Download Information
Mehr

SHS invests in innovative heart valve-repair start-up CoreMedic

Tuebingen, 1 August 2017. SHS Gesellschaft für Beteiligungsmanagement is investing in CoreMedic, a start-up developing innovative, transfemoral repair systems to treat heart valve malfunctions. SHS is investing from its fourth fund generation to finance CoreMedic’s further growth and the clinical application of its innovative products.     Download Information
Mehr

New Kalle Roasted Flavor casing – A roasted flavor without the disadvantages of deep-frying

Wiesbaden, July 21, 2017 – Meat and sausages don’t actually need to be deep-fried to look and taste that way; they just need Kalle’s new Roasted Flavor sausage casing. Roasted aromas and the distinctive “deep-fried” appearance are achieved without even touching a fryer. Instead, the flavor and the crust are infused through the Roasted Flavor casing straight onto the surface of the filling – in just one step. This considerably reduces the amount of time spent in production while making the product safer and avoiding the negative effects generally associated with deep-frying. These improvements save significant amounts of energy, eliminate the risk of fire that deep-frying poses, and make the acts of cleaning equipment and disposing of used fat obsolete. On top of that, there is no need to fear any of the usual risks that come with the act of deep-frying at high temperatures – not to mention the content of the frying fat itself. Around 15 percent of cooked meat products and their vegetarian variations currently found in supermarkets are deep-fried. The Roasted Flavor casing is suitable for all of these types of products, and it is already available now.   Download Information
Mehr

MidCapMonitor by GCA Altium: Sharp increase in alternative financing in the German LBO market

Debt funds have significantly improved their product offerings.  Munich, Frankfurt, Zurich, 14 July 2017. The German mid-cap LBO market generated another round of strong growth in the first half of 2017. The latest MidCapMonitor prepared by the investment bank GCA Altium that regularly analyses leveraged buyout finance transactions with a credit volume of between EUR 20 million and 500 million recorded 41 transactions in the first six months of 2017. This represents a rise of 46% compared with the same period last year.       Download Information
Mehr

numares AG achieves key milestone: identifies candidate metabolomic network for bladder cancer diagnostics

Completes enrollment of prospective study (BLADE) to advance second software-based AXINON® IVD test Regensburg, Germany, 13 July 2017 – numares AG obtained promising results from a retrospective study that provides initial evidence that evaluation of metabolomic biomarker networks can be used as a non-invasive diagnostic for bladder cancer. Based on these results, the company enrolled patients in a prospective study to confirm and further refine the metabolomic network. The test is intended to be launched as a CE-marked in-vitro diagnostics (IVD) in Europe in the second half of 2018.     Download Information
Mehr

European Tyres Distribution Limited, the owner of Fintyre, acquires REIFF’s Tyre and Automotive Technology division, a subsidiary of the REIFF Group, as part of strategy to create a European leader in tyre distribution

LONDON / REUTLINGEN, June 26, 2017 – European Tyres Distribution Limited, the UK strategic platform company owner of Fintyre, today announced that it has signed a definitive agreement to acquire REIFF’s Tyre distribution and Automotive Technology division, the leading independent multi-channel tyre distributor in Germany.   Download Information
Mehr

€1.1 billion capital raised in 2016: Golding Capital Partners beats its previous year’s record again

Munich, 12th April 2017 – Golding Capital Partners (GCP) closed 2016 with another record performance. Almost €1.1 billion capital was raised from institutional investors in Europe, over 30 percent more than in 2015. GCP is securing its leading position in the European market for diversified buyout, private debt and infrastructure investment programmes by systematically expanding its senior management team.     Download Information
Mehr

numares announces commercial launch of renalTX-SCORE®

Regensburg, Germany, 4 April 2017 – Fast-growing innovative diagnostics company numares AG today announced the commercial launch of its new non-invasive test renalTX-SCORE® for the diagnosis of kidney rejection. It is the first test available worldwide evaluating a metabolic biomarker network rather than single biomarkers or tissue biopsy for the diagnosis of an acute rejection reaction following a kidney transplant. renalTX-SCORE will be marketed in Europe as a CE-marked in-vitro diagnostic test (IVD).   Download Information
Mehr

Private debt fund from Golding Capital Partners receives capital commitments of €331 million at first closing

Munich, 4 April 2017 – Golding Capital Partners (GCP) has received commitments of €331 million for its private debt investment programme Golding Private Debt 2016. After just five months of fundraising this means 55 per cent of the €600 million target volume has already been secured at first closing.   Download Information
Mehr

numares AG and Oxford University to collaborate on development of Multiple Sclerosis diagnostic test

Regensburg, Germany, and Oxford, UK, 28 March 2017 – Fast-growing innovative diagnostics company numares AG and Oxford University are collaborating to develop an in-vitro diagnostic (IVD) test to improve therapeutic decision making for patients with multiple sclerosis (MS). The foundation for test development is based on published research conducted at Oxford to differentiate MS patients by metabolic biomarkers using nuclear magnetic resonance spectra. numares will provide its Magnetic Group Signaling® (MGS®) technology at Oxford to enable researchers to rapidly advance their research toward the creation of a non-invasive diagnostic test.       Download Information
Mehr